CHARM Therapeutics
AI-driven drug discovery company developing a next-generation menin inhibitor for acute myeloid leukaemia, based in London and Cambridge.
charmtx.com ↗Why it's here
Raised an $80M Series B led by NEA and SR One in September 2025, bringing total funding to over $150M.
source: uk.finance.yahoo.com- Focus
- AI Drug Discovery
- Founded
- 2021
- Total raised
- $150M+source: uk.finance.yahoo.com
- Latest round
- Series B, $80M, Sep 2025
- London office
- The Stanley Building, 7 Pancras Square, Camden N1C 4AGsource: charmtx.com
- London presence
- HQsource: cyberdb.co
- Investors
- New Enterprise Associates (lead), SR One (lead), F-Prime Capital, Khosla Ventures, NVIDIA, OrbiMedsource: uk.finance.yahoo.com
- Area
- King's Cross
- Nearest station
- King's Cross & St Pancras International, 225 m
- Companies House
- CHARM THERAPEUTICS LIMITED (13641471, active)Incorporated 24 Sep 2021 · SIC 62090, 72110
- Visas
- Licensed visa sponsor, listed as Charm Therapeutics Limitedsource: gov.uk
Verified 6 Oct 2026. How we verify · Suggest a fix
For CHARM Therapeutics
Work here? Show you're on the map. Add the badge to your site or README, or share the listing.
<a href="https://londonmempool.co.uk/c/charm-therapeutics"><img src="https://londonmempool.co.uk/badge/charm-therapeutics.svg" alt="CHARM Therapeutics is listed on London Mempool" width="361" height="28"></a>
Add ?theme=light to the image URL for light backgrounds.